Join the DDA or

Bricanyl recall

Precautionary measure

May 18th 2021

Tagged: MHRA alert

By Ailsa Colquhoun

AstraZeneca UK is recalling one batch of Bricanyl Injection (terbutaline sulfate) 0.5 mg/ml solution for injection or infusion. This is due to out of specification results for a routinely tested known impurity during stability testing. The affected batch is

Batch NumberExpiry DatePack SizeFirst Distributed
F1029-1August 20215 x 1 mL ampoulesNovember 2019

Healthcare professionals are asked to quarantine all remaining stock and return it to the supplier using the supplier’s approved process.

For more information or medical information queries please contact: Tel: +44 (0) 0800 783 0033; email: medical.informationuk@astrazeneca.com

For supply queries, please contact:  Tel: +44 (0) 800 783 0033 (option 1); email: supply.chain@astrazeneca.com